# Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

> **NCT03079089** · NA · COMPLETED · sponsor: **Association for Training, Education, and Research in Hematology, Immunology, and Transplantation** · enrollment: 40 (actual)

## Conditions studied

- Refractory or Relapsed Lymphoid Haemopathy

## Interventions

- **DRUG:** Sequential Packaging (SET)
- **DRUG:** Transfusion graft
- **DRUG:** Prevention of GVHD
- **DRUG:** Care supports
- **DRUG:** Lymphocyte injection of prophylactic donor (PDLI)

## Key facts

- **NCT ID:** NCT03079089
- **Lead sponsor:** Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2023-09-11
- **Final completion:** 2023-09-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03079089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03079089, "Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03079089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*